NCT06612710 - The Safety and Efficacy of NouvSoma001 in Ischemic Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2027

Conditions

Ischemic Stroke

Interventions

DRUG

extracellular vesicles derived from human induced neural stem cell for intravenous injection

extracellular vesicles derived from human induced neural stem cell for intravenous injection（4×10\^9 particles/kg）

DRUG

a placebo of extracellular vesicles derived from human induced neural stem cell for intravenous injection

extracellular vesicles placebo (4×10\^9 particles/kg)

Trial Locations (1)

RECRUITING

Tongji Hospital affiliated to Tongji Medical College of Huazhong University ofScience and Technology, Wuhan

All Listed Sponsors

collaborator

iRegene Therapeutics Co., Ltd.

INDUSTRY

lead

Wei Wang

OTHER